Examination of the mechanism(s) involved in doxorubicin-mediated iron accumulation in ferritin: Studies using metabolic inhibitors, protein synthesis inhibitors, and lysosomotropic agents

被引:64
作者
Kwok, JC [1 ]
Richardson, DR [1 ]
机构
[1] Childrens Canc Inst Australia Med Res, Iron Metab & Chelat Program, Randwick, NSW 2031, Australia
关键词
D O I
10.1124/mol.65.1.181
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Anthracyclines are potent anticancer agents, but their use is limited by cardiotoxicity at high cumulative doses. The mechanisms involved in anthracycline-mediated cardiotoxicity are still poorly understood, but numerous investigations have indicated a role for iron in this process. Our previous studies using neoplastic and myocardial cells showed that anthracyclines inhibit iron mobilization from the iron storage protein, ferritin, resulting in marked accumulation of ferritin-iron. Although the process of ferritin-iron mobilization is little understood, catabolism of ferritin by lysosomes may be a likely mechanism. Because anthracyclines have been shown to accumulate in lysosomes, this latter organelle may be a potential target for these drugs. The present study demonstrated, using native polyacrylamide gel electrophoresis-Fe-59 autoradiography, that ferritin-Fe-59 mobilization is an energy-dependent process that also requires protein synthesis. Depression of lysosomal activity via the enzyme inhibitors E64d [(2S, 3S)-trans-epoxysuccinyl-methylbutane ethyl ester] and leupeptin or the lysosomotropic agents ammonium chloride, chloroquine, and methylamine resulted in a 3- to 5-fold increase in Fe-59-ferritin accumulation compared with control cells. In addition, the proteasome inhibitors N-benzoyloxycarbonyl (Z)-Leu-Leu-leucinal (MG132) and lactacystin also significantly increased Fe-59-ferritin levels compared with control cells. These effects of lysosomotropic agents or inhibitors of lysosomal activity were comparable with that observed with the anthracycline doxorubicin. Collectively, our study indicates a role for lysosomes and proteasomes in ferritin-iron mobilization, and this pathway is dependent on metabolic energy and protein synthesis. Furthermore, the lysosome/proteasome pathway may be a novel anthracycline target, inhibiting iron mobilization from ferritin that is essential for vital iron-requiring processes such as DNA synthesis.
引用
收藏
页码:181 / 195
页数:15
相关论文
共 40 条
[21]   Role of iron in the potentiation of anthracycline cardiotoxicity: Identification of heart cell mitochondria as a major site of iron-anthracycline interaction [J].
Link, G ;
Tirosh, R ;
Pinson, A ;
Hershko, C .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1996, 127 (03) :272-278
[22]   TRANSLOCATION AND CLUSTERING OF ENDOSOMES AND LYSOSOMES DEPENDS ON MICROTUBULES [J].
MATTEONI, R ;
KREIS, TE .
JOURNAL OF CELL BIOLOGY, 1987, 105 (03) :1253-1265
[23]   INHIBITION OF CALPAIN IN INTACT PLATELETS BY THE THIOL PROTEASE INHIBITOR-E-64D [J].
MCGOWAN, EB ;
BECKER, E ;
DETWILER, TC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 158 (02) :432-435
[24]   The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase iron regulatory protein-1 in cytosolic fractions from human myocardium [J].
Minotti, G ;
Recalcati, S ;
Mordente, A ;
Liberi, G ;
Calafiore, M ;
Mancuso, C ;
Preziosi, P ;
Cairo, G .
FASEB JOURNAL, 1998, 12 (07) :541-552
[25]   FLUORESCENCE PROBE MEASUREMENT OF INTRALYSOSOMAL PH IN LIVING CELLS AND PERTURBATION OF PH BY VARIOUS AGENTS [J].
OHKUMA, S ;
POOLE, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (07) :3327-3331
[26]   EFFECTS OF SELECTIVE-INHIBITION OF CATHEPSIN-B AND GENERAL INHIBITION OF CYSTEINE PROTEINASES ON LYSOSOMAL PROTEOLYSIS IN RAT-LIVER INVIVO AND INVITRO [J].
OHSHITA, T ;
NIKAWA, T ;
TOWATARI, T ;
KATUNUMA, N .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 209 (01) :223-231
[27]   Novel cellular defenses against iron and oxidation: Ferritin and autophagocytosis preserve lysosomal stability in airway epithelium [J].
Persson, HL ;
Nilsson, KJ ;
Brunk, UT .
REDOX REPORT, 2001, 6 (01) :57-63
[28]   Endolysosomal proteolysis and its regulation [J].
Pillay, CS ;
Elliott, E ;
Dennison, C .
BIOCHEMICAL JOURNAL, 2002, 363 (03) :417-429
[29]   Iron in cytosolic ferritin can be recycled through lysosomal degradation in human fibroblasts [J].
Radisky, DC ;
Kaplan, J .
BIOCHEMICAL JOURNAL, 1998, 336 :201-205
[30]   The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents .2. The mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone [J].
Richardson, DR ;
Milnes, K .
BLOOD, 1997, 89 (08) :3025-3038